Neonatology pp 21-25 | Cite as

Risk Factors for Gestational Diseases

  • Maria De Bonis
  • Michela Torricelli
  • Felice Petraglia


Preterm delivery (PTD) and pre-eclampsia (PE) are severe pathologies that may affect and compromise the course of pregnancy, and adverse pregnancy outcomes are important causes of perinatal morbidity and mortality [1].


Preterm Delivery Bacterial Vaginosis Placental Abruption Placenta Praevia Uteroplacental Blood Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Plunkett J, Borecki I, Morgan T et al (2008) Population-based estimate of sibling risk for preterm birth, preterm premature rupture of membranes, placental abruption and pre-eclampsia. BMC Genetic 9:44CrossRefGoogle Scholar
  2. 2.
    Iams J (1998) Prevention of preterm birth. N Engl J Med 338:54–56PubMedCrossRefGoogle Scholar
  3. 3.
    Lockwood CJ (2002) Predicting premature delivery-no easy task. N Engl J Med 346:282–284PubMedCrossRefGoogle Scholar
  4. 4.
    Romero R, Espinoza J, Kusanovic JP et al (2006) The preterm parturition syndrome. BJOG 113(Suppl 3):17–42PubMedGoogle Scholar
  5. 5.
    Goldenberg RL, Culhane JF (2005) Pregnancy health status and the risk of preterm delivery. Arch Pediatr Adolesc Med 159:89–90PubMedCrossRefGoogle Scholar
  6. 6.
    Goldenberg RL, Goepfert AR, Ramsey PS (2005) Biochemical markers for the prediction of preterm birth. An J Obste Gynecol 192:36–46CrossRefGoogle Scholar
  7. 7.
    Goldenberg RL, Cliver SP, Mulvihill FX et al (1996) Medical, psychosocial, and behavioural risk factors do not explain the increased risk for low birth weight among blackwomen. Am J Obstet Gynecol 175:1317–1324PubMedCrossRefGoogle Scholar
  8. 8.
    Smith LK, Draper ES, Manktelow BN et al (2007) Socioeconomic inequalities in very preterm birth rates. Arch Dis Child Fetal Neonatal Ed 92:F11–14PubMedCrossRefGoogle Scholar
  9. 9.
    Goldenberg RL, Andrews WW, Faye O et al (2006) The Alabama preterm birth project: placental histology in recurrent spontaneous and indicated preterm birth. Am J Obstet Gynecol 195:792–796PubMedCrossRefGoogle Scholar
  10. 10.
    Smith GC, Pell JP, Dobbie R (2003) Interpregnancy interval and risk of preterm birth and neonatal death: retrospective cohort study. BMJ 327:313PubMedCrossRefGoogle Scholar
  11. 11.
    Tamura T, Goldenberg RL, Freeberg LE et al (1992) Maternal serum folate and zinc concentrations and their relationship to pregnancy outcome. Am J Clin Nutr 56:365–370PubMedGoogle Scholar
  12. 12.
    Goldenberg JF, Johnson DC (2005) Maternal infection and adverse fetal and neonatal outcomes. Clin Perinatol 32:523–559PubMedCrossRefGoogle Scholar
  13. 13.
    Offenbacher S, Katz V, Fertik G et al (1996) Periodontal infections as a possible risk factor for preterm low birth weight. J Periodontol 67:1103–1113PubMedGoogle Scholar
  14. 14.
    Jakobsson M, Gissler M, Sainio S et al (2007) Preterm delivery after surgical treatment for cervical intraepithelial neoplasia. Obstet Gynecol 109:309–313PubMedCrossRefGoogle Scholar
  15. 15.
    Berkowitz GS, Lapinski RH, Lockwood CJ et al (1996) Corticotropin-releasing factor and its binding protein: maternal serum levels in term and preterm deliveries. Am J Obstet Gynecol 174:1477–1483PubMedCrossRefGoogle Scholar
  16. 16.
    Ebrahim SH, Floyd RL, Merritt RK et al (2000) Trends in pregnancy related smoking rates in the United States, 1987–1996. JAMA 283:361–366PubMedCrossRefGoogle Scholar
  17. 17.
    Watts DH, Krohn MA, Hillier SL, Eschenbach DA (1992) The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol 79:351–357PubMedCrossRefGoogle Scholar
  18. 18.
    Krupa FG, Faltin D, Cecatti JG et al (2006) Predictors of preterm birth Int J Gynaecol Obstet 94:5–11Google Scholar
  19. 19.
    Hillier SL, Krohn MA, Cassen E et al (1994) The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. Clin Infect Dis 20:S276–278CrossRefGoogle Scholar
  20. 20.
    Andrews WW, Copper RL, Hauth JC et al (2000) Second-trimester cervical ultrasound: associations with increased risk for recurrent early, spontaneous delivery. Obstet Gynecol 95:222–226PubMedCrossRefGoogle Scholar
  21. 21.
    Goldenberg RL, Mercer BM, Meis PJ et al (1996) The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol 87:643–648PubMedCrossRefGoogle Scholar
  22. 22.
    Wang X, Zuckerman B, Kaufman G (2001) Molecular epidemiology of preterm delivery: methodology and challenges. Paediatr Perinat Epidemiol 15:63–77PubMedCrossRefGoogle Scholar
  23. 23.
    Reis FM, D’Antona D, Petraglia F (2002) Predictive Value of Hormone Measurements in Maternal and Fetal Complications of Pregnancy. Endocrine Reviews 23:230–257PubMedCrossRefGoogle Scholar
  24. 24.
    Sibai M, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365:785–799PubMedGoogle Scholar
  25. 25.
    Sibai BM (2005) Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 105:402–410PubMedCrossRefGoogle Scholar
  26. 26.
    Dekker G, Sibai B (2001) Primary, secondary, and tertiary prevention of pre-eclampsia. The Lancet 357:209–215CrossRefGoogle Scholar
  27. 27.
    Sibai BM, Mercer B, Sarinoglu C (1991) Severe pre-eclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 165:1408–1412PubMedGoogle Scholar
  28. 28.
    Sibai BM, Gordon T, Thom E et al (1995) Risk factors for pre-eclampsia in healty nulliparous women: a prospective multicenter study. Am J Obstet Gynecol 172:642–648PubMedCrossRefGoogle Scholar
  29. 29.
    Siddiqi T, Rosenn B, Mimouni F et al (1991) Hypertension during pregnancy in insulin-dependent diabetic women. Obstet Gynecol 77:514–519PubMedGoogle Scholar
  30. 30.
    Dizon-Townson DS, Nelson LM, Easton K, Ward K (1996) The Factor V Leiden mutation may predispose woman to severe pre-eclampsia. Am J Obstet Gynecol 175:902–905PubMedCrossRefGoogle Scholar
  31. 31.
    Dekker GA, Sibai BM (1998) Etiology and pathophysiology of pre-eclampsia: current concepts. AJOG Review. Am J Obstet Gynecol 179:1359–1375PubMedCrossRefGoogle Scholar
  32. 32.
    Dekker GA, de Vries JI, Doelitzsch PM et al (1995) Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 173:1042–1048PubMedCrossRefGoogle Scholar
  33. 33.
    Klonoff-Cohen HS, Cross JL, Pieper CF (1996) Job stress and pre-eclampsia. Epidemiology 7:245–249PubMedCrossRefGoogle Scholar
  34. 34.
    Coonrod DV, Hickok DE, Zu K et al (1995) Risk factors for pre-eclampsia in twin pregnancies: a population-based cohortstudy. Obstet Gynecol 85:645–650PubMedCrossRefGoogle Scholar
  35. 35.
    Vesce F, Farina A, Giorgetti M et al (1997) Increased incidence of pre-eclampsia in pregnancies complicated by fetal malformation. Gynecol Obstet Invest 44:107–111PubMedCrossRefGoogle Scholar
  36. 36.
    Tuohy JF, James DK (1992) Preeclampsia and trisomy. Br J Obstet Gynecol 99:891–894CrossRefGoogle Scholar
  37. 37.
    Kaaja R (2008) Predictors and risk factors of pre-eclampsia. Minerva Gynecol 60:421–429Google Scholar
  38. 38.
    Chien PF, Arnott N, Gordon A et al (2000) How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview. BJOG 107:196–208PubMedCrossRefGoogle Scholar
  39. 39.
    Lambert-Messerlian GM, Silver HM, Petraglia F et al (2000) Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin A as predictors of preeclampsia in the third trimester of pregnancy. J Soc Gynecol Investig 7:170–174PubMedCrossRefGoogle Scholar
  40. 40.
    D’Antona D, Reis FM, Benedetto C et al (2000) Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders. J Endocrinol 165:157–162PubMedCrossRefGoogle Scholar
  41. 41.
    Jackson N, Biddolph SC, Ledger W et al (2000) Inhibin expression in normal and pre-eclamptic placental tissue. Int J Gynecol Pathol 19:219–224PubMedCrossRefGoogle Scholar
  42. 42.
    Caniggia I, Lye SJ, Cross JC (1997) Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology 138:3976–3986PubMedCrossRefGoogle Scholar
  43. 43.
    Muttukrishna S, North RA, Morris J et al (2000) Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 15:1640–1645PubMedCrossRefGoogle Scholar
  44. 44.
    Chaiworapongsa T, Romero R, Espinoza J et al (2004) Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol 190:1641–1647CrossRefGoogle Scholar
  45. 45.
    Baumann MU, Bersinger NA, Surbek DV (2007) Serum markers for predicting pre-eclampsia. Mol Aspects Med 28:227–244PubMedCrossRefGoogle Scholar
  46. 46.
    Giudice LC, Conover CA, Bale L et al (2002) Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblast and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. J Clin Endocrinol Metab 87:2359–2366PubMedCrossRefGoogle Scholar
  47. 47.
    Bersinger NA, Smàrason AK, Muttukrishna S et al (2003) Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin. Hypertens Pregnancy 22:45–55PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Maria De Bonis
    • 1
  • Michela Torricelli
  • Felice Petraglia
  1. 1.Department of Pediatrics, Obstetrics and Reproductive Medicine Section of Obstetrics and GynecologyUniversity of SienaSienaItaly

Personalised recommendations